Johnson & Johnson and Arcutis support skin care educational video series

With support from Johnson & Johnson and Arcutis Biotherapeutics, the Skin of Color Society (SOCS) on Monday released the first in a series of educational videos on skin care issues in patients of color.

The videos are based on the content of the SOCS Media Day 2024 in March and were released in two sections: “Ask the Experts” and “MelanantED”.

Both series serve to educate patients, physicians and the general public about dermatological diseases that affect people of color.

In the “Ask the Expert” series, SOCS experts discuss a variety of topics including psoriasis, seborrheic dermatitis, aging, skin care routines and sunscreen use.

MelanatED is an expansion of last year’s existing series and covers topics such as hair styling, acne on skin of color, and misinformation on social media.

In addition to J&J and Arcutis, the videos are also sponsored by Procter & Gamble, Clinique and EltaMD.

This latest publication aligns with SOCS’ mission to increase diversity in dermatology and educate dermatologists to provide culturally competent care. It also supports SOCS’ ongoing health equity efforts through digital media channels.

“We are thrilled to share these insightful videos as part of our deep commitment to educating our patients, our colleagues and the public,” SOCS President Dr. Victoria Barbosa said in a statement. “As dermatologists and SOCS members, we are passionate about providing excellent patient care and achieving health equity for all.”

This video series release is the first of many, as SOCS has announced plans to release more educational clips throughout the year.

For J&J, sponsoring this series comes months after the pharmaceutical giant announced partnerships with more than 100 different organizations working to eliminate inequities for BIPOC patients across the country.

J&J recently released data showing that its psoriasis drug Tremyfa is safe and effective for patients of all skin tones.

As for Acrutis, the drugmaker launched a campaign on seborrheic dermatitis in late 2023. The campaign included testimonials from patients with dark skin, as well as educational information on how the disease manifests itself in darker skin tones.

These companies are not alone in this effort, as the mission of health equity in skin care is resonating across the pharmaceutical industry.

Eli Lilly recently launched the latest edition of its “Get Better” campaign, focusing on the skin and health disparities faced by patients of color.